# Selective Tibial Nerve Block vs Local Infiltration Analgesia After Prothetic Knee Surgery

> **NCT03698006** · NA · COMPLETED · sponsor: **Centre Hospitalier Universitaire Vaudois** · enrollment: 60 (actual)

## Conditions studied

- Postoperative Pain
- Knee Osteoarthritis

## Interventions

- **DRUG:** Ropivacaine 0.5% Injectable Solution
- **DRUG:** Ropivacaine 0.2% Injectable Solution

## Key facts

- **NCT ID:** NCT03698006
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-12
- **Primary completion:** 2022-01-31
- **Final completion:** 2022-06-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03698006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03698006, "Selective Tibial Nerve Block vs Local Infiltration Analgesia After Prothetic Knee Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03698006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
